InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,268.00
(
-0.72%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
85.02
(
0.38%
)
Bitcoin
65,040.05
(
0.11%
)
Post# of 252271
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: mcbio post# 156535

Wednesday, 02/06/2013 12:16:22 AM

Wednesday, February 06, 2013 12:16:22 AM

Post# of 252271

What is your prediction of what will be the first viable oral combo for GT3?




GILD has another NS5A (GS-5816) in Phase 1. Sofosbuvir/GS-5816 could be first to market in GT3 if GILD doesn't license or partner any other compounds.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up